Clinical trial
Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
NCT00803816 is registered in ClinicalTrials.gov with Carsten Heinz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
- Lead sponsor
- Carsten Heinz
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- December 31, 2010
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.